Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | CTSK | P43235 | 5/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 6/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.35 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22661070 | 0.90 | PTPN1 (0.45) | EPHX2CTSKPTPN1CTSSCTSL | |
| SCHEMBL21837898 | 0.81 | IDO1 (0.43) | EPHX2CTSKPTPN1CTSSIDO1 | |
| SCHEMBL21837902 | 0.81 | IDO1 (0.43) | EPHX2CTSKPTPN1CTSSIDO1 | |
| SCHEMBL31524118 | 0.80 | EPHX2 (0.48) | EPHX2CTSKTDP1POLBMAPT | |
| SCHEMBL23923063 | 0.79 | PPARA (0.52) | EPHX2CTSKPTPN1CTSSCTSL | |
| SCHEMBL22108617 | 0.79 | PPARA (0.52) | EPHX2CTSKPTPN1CTSSCTSL | |
| SCHEMBL7244749 | 0.77 | HDAC4 (0.37) | EPHX2CTSKCTSS | |
| SCHEMBL28575351 | 0.76 | CACNA1H (0.46) | EPHX2TDP1CYP1A2HTT | |
| SCHEMBL29099180 | 0.74 | NPSR1 (0.49) | EPHX2TDP1MAPTHTTMEN1 | |
| SCHEMBL31524222 | 0.73 | CYP1A2 (0.39) | EPHX2CTSKTDP1MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263459-A1 | STABILIZED PACAP PEPTIDE | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2025-08-21 | — | — | US | disclosed |
| EP-3974027-B1 | STABILIZED PACAP PEPTIDE | SENJU PHARMA CO (JP) | 2024-10-23 | — | — | EP | disclosed |
| EP-3974027-A1 | STABILIZED PACAP PEPTIDE | Senju Pharmaceutical Co., Ltd. (JP) | 2022-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263459-A1 | STABILIZED PACAP PEPTIDE | GRIK5, VGF, NPY5R | EPHX2 4202/4885CTSK 302/4885TDP1 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.